Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research.

Current Issue

April 2023 (Vol. 43 Issue 4) Table of Contents
Anticancer Research: 43 (4)

Issue highlights

  • Preclinical Activity of 4-Demethyl-4-cholesteryloxycarbonylpenclomedine in Melanoma
  • EZH2 Expression Correlates With T-Cell Infiltration in Oral Leukoplakia and Predicts Cancer Transformation
  • Surgical Treatments for Ductal Carcinoma In Situ (DCIS) in Elderly Patients

 

 

 

 

Our Special Issue of ANTICANCER RESEARCH on 

"NEW ANTICANCER AGENTS" is now online.

 

Featured Articles

  • Patient-derived Orthotopic Xenograft (PDOX) Nude Mouse Model of Soft-tissue Sarcoma More Closely...
    February 09, 2015
  • Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and...
    September 25, 2015
  • The Effect of Various Doses of Oral Vitamin D3 Supplementation on Gut Microbiota in...
    December 31, 2019
  • Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a...
    December 30, 2014
  • Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-...
    December 30, 2014
  • A Long Noncoding RNA, lncRNA-ATB, Is Involved in the Progression and Prognosis of Colorectal Cancer
    March 06, 2015

Latest Articles

  • Open Access
    Surgical Treatments for Ductal Carcinoma In Situ (DCIS) in Elderly Patients
    ORESTE CLAUDIO BUONOMO, MARCO PELLICCIARO, MARCO MATERAZZO, SIMONE BERARDI, PAOLA ELDA GIGLIOTTI, JONATHAN CASPI, ROSARIA MEUCCI, TOMMASO PERRETTA, ILARIA PORTARENA, MARIO DAURI, CHIARA ADRIANA PISTOLESE and GIANLUCA VANNI
    Anticancer Research April 2023, 43 (4) 1555-1562; DOI: https://doi.org/10.21873/anticanres.16305
  • You have access
    Pelvic Neoadjuvant Radiotherapy for Stage M1a Rectal Adenocarcinoma Patients Treated With Systemic Therapy Followed by Proctectomy and Metastasectomy: A Nationwide Retrospective Cohort Study
    TAO-WEI KE, SHENG-CHI CHANG, HUNG-CHANG CHEN, HWEI-MING WANG, WILLIAM TZU-LIANG CHEN, YI-CHANG CHEN, MING-HAO HSIEH, YUAN-YAO TSAI, CHENG-WEI HUANG, YU-MIN LIAO, CHE-HUNG LIN, CHUN-LIN HUANG, LIANG-CHI CHEN and CHUN-RU CHIEN
    Anticancer Research April 2023, 43 (4) 1843-1851; DOI: https://doi.org/10.21873/anticanres.16338
  • You have access
    Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer
    STEFAN STEFANOVIC, RALPH WIRTZ, MARC SÜTTERLIN, UROS KARIC, ANDREAS SCHNEEWEISS, THOMAS M. DEUTSCH and MARKUS WALLWIENER
    Anticancer Research April 2023, 43 (4) 1449-1454; DOI: https://doi.org/10.21873/anticanres.16293
  • Open Access
    Expression of Eukaryotic Translation Initiation Factors in the Urothelial Carcinoma of the Bladder
    JETON LUZHA, NORBERT NASS, PIOTR CZAPIEWSKI, NICOLAS SCHROEDER, THOMAS KALINSKI, MARTIN SCHOSTAK, CHRISTOPH SCHATZ, BURKHARD JANDRIG and JOHANNES HAYBAECK
    Anticancer Research April 2023, 43 (4) 1437-1448; DOI: https://doi.org/10.21873/anticanres.16292
  • You have access
    Comparison of Quality of Life and Injection Site Reactions After Switching from Degarelix 80 mg to 480 mg in Advanced Prostate Cancer: A Prospective Trial
    KEIICHIRO MIYAJIMA, TAKAFUMI YANAGISAWA, HIROTAKA SUZUKI, WATARU FUKUOKAYA, KEIGO SAKANAKA, KOKI OBAYASHI, JUN MIKI and TAKAHIRO KIMURA
    Anticancer Research April 2023, 43 (4) 1611-1621; DOI: https://doi.org/10.21873/anticanres.16311
  • You have access
    Giant Cell Angiofibroma in the Buccal Mucosa – A Rising Entity?
    FLORIAN DUDDE, FILIP BARBAREWICZ, THOMAS TELSCHOW, ADRIAN ZU KNYPHAUSEN and KAI-OLAF HENKEL
    Anticancer Research April 2023, 43 (4) 1869-1871; DOI: https://doi.org/10.21873/anticanres.16342
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention

Visit the official website of Anticancer Research.
Back to top
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire